Adherium has announced that its Smartinhaler has been selected for use in the myAirCoach project, which will study the effectiveness of mHealth systems for asthma control. The program, which includes participation by Imperial College London, the University of Manchester, and Leiden University Medical Center, is funded through the European Commission’s Horizon 2020 research and innovation program.
Adherium Founder and CEO Garth Sutherland commented, “Successful disease management and prevention is only truly achieved by understanding the real-world complexity of our lives. The best way to do that is through rich data collected in the real world. By providing our innovative solutions to people with asthma, we can help people take the right medicine, at the right dose, at the right time and in the right way. The myAirCoach program is a leading initiative assessing the impact that digital health solutions, such as Smartinhaler, can have on patients in a real-world setting. It is a major international project, funded by the prestigious European Union Horizon 2020 framework.”
Fan Chung, Professor of Respiratory Medicine and Head of Experimental Studies Medicine at the National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, said, “People with asthma are more likely to miss school or work and experience reduced quality of life. We are excited about the collaboration between Adherium and myAirCoach which is expected to set the basis for the widespread adoption of sensor-based self-management systems across the spectrum of respiratory diseases.”
Read the Adherium press release.
